These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24028392)

  • 1. Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cells.
    Meregalli M; Navarro C; Sitzia C; Farini A; Montani E; Wein N; Razini P; Beley C; Cassinelli L; Parolini D; Belicchi M; Parazzoli D; Garcia L; Torrente Y
    FEBS J; 2013 Dec; 280(23):6045-60. PubMed ID: 24028392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid accumulation in dysferlin-deficient muscles.
    Grounds MD; Terrill JR; Radley-Crabb HG; Robertson T; Papadimitriou J; Spuler S; Shavlakadze T
    Am J Pathol; 2014 Jun; 184(6):1668-76. PubMed ID: 24685690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasomal inhibition restores biological function of mis-sense mutated dysferlin in patient-derived muscle cells.
    Azakir BA; Di Fulvio S; Kinter J; Sinnreich M
    J Biol Chem; 2012 Mar; 287(13):10344-10354. PubMed ID: 22318734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient bypass of mutations in dysferlin deficient patient cells by antisense-induced exon skipping.
    Wein N; Avril A; Bartoli M; Beley C; Chaouch S; Laforêt P; Behin A; Butler-Browne G; Mouly V; Krahn M; Garcia L; Lévy N
    Hum Mutat; 2010 Feb; 31(2):136-42. PubMed ID: 19953532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro.
    Tanaka A; Woltjen K; Miyake K; Hotta A; Ikeya M; Yamamoto T; Nishino T; Shoji E; Sehara-Fujisawa A; Manabe Y; Fujii N; Hanaoka K; Era T; Yamashita S; Isobe K; Kimura E; Sakurai H
    PLoS One; 2013; 8(4):e61540. PubMed ID: 23626698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of pseudoexon splicing caused by a novel intronic dysferlin mutation.
    Dominov JA; Uyan Ö; McKenna-Yasek D; Nallamilli BRR; Kergourlay V; Bartoli M; Levy N; Hudson J; Evangelista T; Lochmuller H; Krahn M; Rufibach L; Hegde M; Brown RH
    Ann Clin Transl Neurol; 2019 Apr; 6(4):642-654. PubMed ID: 31019989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with a non-dysferlin Miyoshi myopathy have a novel membrane repair defect.
    Jaiswal JK; Marlow G; Summerill G; Mahjneh I; Mueller S; Hill M; Miyake K; Haase H; Anderson LV; Richard I; Kiuru-Enari S; McNeil PL; Simon SM; Bashir R
    Traffic; 2007 Jan; 8(1):77-88. PubMed ID: 17132147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report of an adolescent girl with limb-girdle muscular dystrophy type 2B - the usefulness of muscle protein immunostaining in the diagnosis of dysferlinopathies.
    Szymanska S; Rokicki D; Karkucinska-Wieckowska A; Szymanska-Debinska T; Ciara E; Ploski R; Grajkowska W; Pronicki M
    Folia Neuropathol; 2014; 52(4):452-6. PubMed ID: 25574751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice.
    Benchaouir R; Meregalli M; Farini A; D'Antona G; Belicchi M; Goyenvalle A; Battistelli M; Bresolin N; Bottinelli R; Garcia L; Torrente Y
    Cell Stem Cell; 2007 Dec; 1(6):646-57. PubMed ID: 18371406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morpholino-Mediated Exons 28-29 Skipping of Dysferlin and Characterization of Multiexon-skipped Dysferlin using RT-PCR, Immunoblotting, and Membrane Wounding Assay.
    Anwar S; Yokota T
    Methods Mol Biol; 2023; 2587():183-196. PubMed ID: 36401031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysferlin mutation in a Chinese pedigree with Miyoshi myopathy.
    Shunchang S; Fan Q; Huacheng W; Leturcq F; Yongjian S; Bingfeng Z; Wen Y; Deburgrave N
    Clin Neurol Neurosurg; 2006 Jun; 108(4):369-73. PubMed ID: 16023782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysferlin and the plasma membrane repair in muscular dystrophy.
    Bansal D; Campbell KP
    Trends Cell Biol; 2004 Apr; 14(4):206-13. PubMed ID: 15066638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
    Flix B; de la Torre C; Castillo J; Casal C; Illa I; Gallardo E
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1927-38. PubMed ID: 23792176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverse engineering gene network identifies new dysferlin-interacting proteins.
    Cacciottolo M; Belcastro V; Laval S; Bushby K; di Bernardo D; Nigro V
    J Biol Chem; 2011 Feb; 286(7):5404-13. PubMed ID: 21119217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Miyoshi distal muscular dystrophy (Miyoshi myopathy)].
    Kawai H
    Brain Nerve; 2011 Feb; 63(2):147-56. PubMed ID: 21301039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy.
    Millay DP; Maillet M; Roche JA; Sargent MA; McNally EM; Bloch RJ; Molkentin JD
    Am J Pathol; 2009 Nov; 175(5):1817-23. PubMed ID: 19834057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations.
    Cacciottolo M; Numitone G; Aurino S; Caserta IR; Fanin M; Politano L; Minetti C; Ricci E; Piluso G; Angelini C; Nigro V
    Eur J Hum Genet; 2011 Sep; 19(9):974-80. PubMed ID: 21522182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice.
    Leriche-Guérin K; Anderson LV; Wrogemann K; Roy B; Goulet M; Tremblay JP
    Neuromuscul Disord; 2002 Feb; 12(2):167-73. PubMed ID: 11738359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient recovery of dysferlin deficiency by dual adeno-associated vector-mediated gene transfer.
    Lostal W; Bartoli M; Bourg N; Roudaut C; Bentaïb A; Miyake K; Guerchet N; Fougerousse F; McNeil P; Richard I
    Hum Mol Genet; 2010 May; 19(10):1897-907. PubMed ID: 20154340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental and tissue-specific regulation of a novel dysferlin isoform.
    Salani S; Lucchiari S; Fortunato F; Crimi M; Corti S; Locatelli F; Bossolasco P; Bresolin N; Comi GP
    Muscle Nerve; 2004 Sep; 30(3):366-74. PubMed ID: 15318348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.